OSTAAT™ is a non-invasive connected medical device designed for people affected by osteopenia or osteoporosis, with or without associated severe chronic kidney disease.
The technology involves applying a low-intensity electric current with no side effects. The current acts on cell membrane mechanisms, allowing calcium to enter the cells, thus promoting bone growth. The technology can be used preventively, to reduce the risk of fractures of all kinds, or curatively, to accelerate the healing process of fractures* caused by osteoporosis, severe chronic kidney disease, or other conditions. At the cutting edge of technology, the OSTAAT™ device in its prototype belt version for clinical studies and its smart clothing version, will be able to be activated via a mobile app accessible on cell phone, tablet, or computer.
*Claims will be addressed in future clinical trials.
Every year, millions of women over 50 are newly diagnosed with osteoporosis and immediately face a dangerous treatment gap. While medications exist, they take 6 to 12 months to begin working, and much longer to show meaningful effects at the hip, the most life-threatening fracture site. During this vulnerable period, patients remain at very high risk of fractures, with no effective short-term protection.
This situation is even more alarming when we consider that nearly 40% of patients refuse medication altogether, most often due to fear of side effects, according to a survey conducted in 2016 by the Bone Health & Osteoporosis Foundation. Among those who start treatment, over 50% will discontinue within one to two years.
OSTAAT™ technology was created to fill this critical and persistent gap, offering immediate, drug-free, non-invasive support for bone health starting at diagnosis.
OSTAAT™ also meets an urgent need in another overlooked population: the 850+ million people worldwide with chronic kidney disease (CKD), including 135 million with advanced CKD. These patients are at high risk of osteoporosis and fractures but are often excluded from pharmacologic treatment due to medical contraindications.
With no safe medication options, CKD patients are left unprotected, facing progressive bone loss, fragile bones, and increased mortality.
OSTAAT™ offers these patients a breakthrough solution, making it possible to proactively manage bone health without drugs.
OSTAAT™ fills a dangerous gap left wide open by conventional treatment.
It's not just an innovation. It's a lifesaving bridge to stronger bones…when patients need it most.
The OSTAAT™ device uses a sophisticated low-intensity electrical current to stimulate bone growth. This innovative and patented technology, the result of rigorous academic research, has undergone extensive studies to elucidate its mechanism of action on osteogenesis.
*Patents pending.
The scientific validation of OSTAAT™ is based on a comprehensive research program:
These multidimensional studies have demonstrated OSTAAT™'s potential as a non-pharmacological alternative for osteoporosis and bone disorders related to chronic kidney disease, particularly for patients intolerant to traditional drug treatments.
The discovery of a link between electrical stimulation and bone growth led to an exhaustive review of scientific literature, generating new hypotheses currently being studied in collaboration with university researchers.
An in vitro study, conducted in partnership with UQAM since August 2022, has confirmed the initial hypothesis on the link between electrical stimulation and bone formation. The results validate the device's voltage parameters, essential for stimulating ion channels responsible for calcium deposition in cells.
These advances will soon be presented at scientific conferences and published in international journals, marking a crucial step towards launching a multicenter clinical study.
OSTAAT™ technology represents a groundbreaking advancement in the treatment of osteopenia and osteoporosis with or without severe chronic kidney disease, offering a unique and innovative approach to bone health management.
By combining cutting-edge technology with a deep understanding of bone physiology, OSTAAT™ offers a safe, effective, and convenient alternative to traditional osteoporosis treatments.
ClinicalValidations.description
ClinicalValidations.loading
